Literature DB >> 24567269

Preliminary findings on the use of osteopathic manipulative treatment: outcomes during the formation of the practice-based research network, DO-Touch.NET.

Brian F Degenhardt1, Jane C Johnson, Shanin R Gross, Celia Hagan, Gregg Lund, William J Curry.   

Abstract

CONTEXT: Few studies have assessed the use of osteopathic manipulative treatment (OMT) and subsequent patient-reported outcomes.
OBJECTIVE: To assess the current use of OMT and associated patient-reported outcomes.
DESIGN: A retrospective medical record review and a prospective observational study.
SETTING: Two university-based sites and their clinics associated with the practice-based research network DO-Touch.NET. PARTICIPANTS: Patients aged 18 years or older who received OMT. MAIN OUTCOME MEASURES: Medical records from 2007 were retrospectively reviewed to identify conditions being managed with OMT. From 2008 to 2010, patients were recruited before seeing their physicians. Questionnaires were distributed to patients and physicians, and information including demographics, chief complaints, symptom severity, current and past treatments, interference of symptoms with quality of life, physical examination findings, diagnoses, OMT performed, and immediate patient response to OMT was collected. A subset of patients provided data on symptom severity and frequency and other treatments daily for the 7 days after OMT. On day 7, symptom interference with quality of life was reassessed.
RESULTS: Retrospective data were collected from 2569 office visits, and prospective data were collected from 299 office visits (patient age range, 18-93 years). In the medical record review, 17 of the top 25 diagnoses (68%) were related to musculoskeletal conditions. In the prospective study, 18 of the top 24 medical diagnoses (75%) were related to musculoskeletal conditions. Immediately after OMT, patients at 271 of 296 office visits (92%) felt better or much better; those at 5 (<2%) felt worse. After 7 days, patients at 126 of 175 office visits (72%) felt better or much better, and those at 10 (6%) felt worse. Average and worst symptom severity decreased until post-OMT days 4 and 5, respectively, when severity leveled off. There was decreased interference of symptoms with quality of life from before OMT to 7 days after OMT in usual/general activities, sleep, mood, and relationships (all P≤.05).
CONCLUSION: These preliminary results suggest that for adults, OMT is predominantly used for managing musculoskeletal pain conditions and is effective for short-term symptom relief. Continued surveillance of DO-Touch.NET member practice outcomes may help identify priorities for osteopathic research and define evidence-based standards for OMT practice and training.

Entities:  

Mesh:

Year:  2014        PMID: 24567269     DOI: 10.7556/jaoa.2014.033

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

1.  Osteopathic Manipulative Treatment Alters Gastric Myoelectric Activity in Healthy Subjects.

Authors:  Edward Shadiack; Noah Jouett; Amber van den Raadt; Roselle Liganor; Jacob Watters; Kendi Hensel; Michael Smith
Journal:  J Altern Complement Med       Date:  2018-10-30       Impact factor: 2.579

2.  Osteopathic Medicine in Four Chronic Musculoskeletal Pain Diseases: An Observational Trial with Follow-Up.

Authors:  Gabriele Rotter; Sylvia Binting; Tatjana Tissen-Diabaté; Miriam Ortiz; Benno Brinkhaus
Journal:  Complement Med Res       Date:  2021-08-19       Impact factor: 1.211

3.  Impact of osteopathic treatment on pain in adult patients with cystic fibrosis--a pilot randomized controlled study.

Authors:  Dominique Hubert; Lucile Soubeiran; Fabrice Gourmelon; Dominique Grenet; Raphaël Serreau; Elodie Perrodeau; Rafael Zegarra-Parodi; Isabelle Boutron
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

4.  Osteopathy modulates brain-heart interaction in chronic pain patients: an ASL study.

Authors:  Francesco Cerritelli; Piero Chiacchiaretta; Francesco Gambi; Raoul Saggini; Mauro Gianni Perrucci; Antonio Ferretti
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.